These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6999314)

  • 21. Induction of hepatic mixed function oxidases by photomirex.
    Mehendale HM; Onoda K; Curtis LR; Ho IK
    J Agric Food Chem; 1979; 27(6):1416-8. PubMed ID: 544674
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of a commercial polybrominated biphenyl mixture, 2,4,5,2',4',5'-hexabromobiphenyl and 2,3,6,7-tetrabromonaphthalene as inducers of liver microsomal drug-metabolizing enzymes.
    Goldstein JA; Linko PC; Levy LA; McKinney JD; Gupta BN; Moore JA
    Biochem Pharmacol; 1979 Oct; 28(19):2947-56. PubMed ID: 229864
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of the drug-metabolizing enzymes' induction by 2-diethylaminoethyl-2-2-diphenylvalerate-HCl (SKF 525 A).
    Fernández G; Villarruel MC; Castro JA
    Toxicol Appl Pharmacol; 1978 Nov; 46(2):315-21. PubMed ID: 734661
    [No Abstract]   [Full Text] [Related]  

  • 24. Pesticides as inducers of hepatic drug-metabolizing enzymes--I. Mixed function oxidase activity.
    Fabacher DL; Kulkarni AP; Hodgson E
    Gen Pharmacol; 1980; 11(5):429-35. PubMed ID: 7419035
    [No Abstract]   [Full Text] [Related]  

  • 25. Porphobilinogen oxygenase induction by 2-allyl-2-isopropylacetamide treatment.
    Tomaro ML; Frydman RB
    FEBS Lett; 1977 Dec; 84(1):29-32. PubMed ID: 590523
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in the effect of drugs due to reciprocal interference with their protein binding and catabolism].
    Remmer H
    Dtsch Med Wochenschr; 1974 Mar; 99(9):413-9. PubMed ID: 4857236
    [No Abstract]   [Full Text] [Related]  

  • 27. DDE-induced microsomal mixed-function oxidases in the puffin. (Fratercula arctica). (Fratercula arctica).
    Bend JR; Miller DS; Kinter WB; Peakall DB
    Biochem Pharmacol; 1977 May; 26(10):1000-1. PubMed ID: 861039
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of microsomal hydroxylases in the modification of chloroform hepatotoxicity in rats.
    Gopinath C; Ford JH
    Br J Exp Pathol; 1975 Oct; 56(5):412-22. PubMed ID: 174709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of drug-metabolizing enzymes by fractionated commercial polybrominated biphenyls (PBBs).
    Robertson L; Parkinson A; Safe S
    Toxicol Appl Pharmacol; 1981 Feb; 57(2):254-62. PubMed ID: 6261418
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical significance of microsomal enzyme induction.
    Breckenridge AM; Roberts JB
    Pharmacol Res Commun; 1976 Jun; 8(3):229-42. PubMed ID: 1026955
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of physicochemical and pharmacokinetic properties of barbiturates on the induction of drug metabolism.
    Pelkonen O; Kärki NT
    Chem Biol Interact; 1973 Aug; 7(2):93-9. PubMed ID: 4766941
    [No Abstract]   [Full Text] [Related]  

  • 32. Categorization of lipophilic xenobiotics by the enthalpic structure-function response of hepatic mixed-function oxidase.
    Hollebone BR
    Drug Metab Rev; 1986; 17(1-2):93-143. PubMed ID: 3536381
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatic enzyme induction by 3-methylcholanthrene-type PCB and development of its toxicity].
    Yoshihara S; Nagata K; Wada I; Koga N; Yoshimura H
    Fukuoka Igaku Zasshi; 1983 May; 74(5):209-16. PubMed ID: 6411562
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities.
    Nebert DW; Eisen HJ; Negishi M; Lang MA; Hjelmeland LM; Okey AB
    Annu Rev Pharmacol Toxicol; 1981; 21():431-62. PubMed ID: 7016012
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fundamentals of drug metabolism].
    Netter KJ
    Arzneimittelforschung; 1972 Feb; 22(2):285-92. PubMed ID: 4402072
    [No Abstract]   [Full Text] [Related]  

  • 36. The induction of hepatic microsomal enzymes by safrole.
    Parke DV; Rahman H
    Biochem J; 1970 Oct; 119(5):53P-54P. PubMed ID: 5492830
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug interactions. 3. Therapeutic implications of enzyme induction.
    Soyka LF
    Pediatrics; 1972 Sep; 50(3):489-90. PubMed ID: 5056430
    [No Abstract]   [Full Text] [Related]  

  • 38. Tobacco smoking and drugs: a clinically important interaction?
    D'Arcy PF
    Drug Intell Clin Pharm; 1984 Apr; 18(4):302-7. PubMed ID: 6370644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between drugs.
    Lant AF
    Trans Med Soc Lond; 1974; 90():142-55. PubMed ID: 4469105
    [No Abstract]   [Full Text] [Related]  

  • 40. Interindividual differences in rates of drug oxidation in man.
    Davies DS; Thorgeirsson SS; Breckenridge A; Orme M
    Drug Metab Dispos; 1973; 1(1):411-7. PubMed ID: 4149412
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.